Literature DB >> 24297684

The expression of the eotaxins IL-6 and CXCL8 in human epithelial cells from various levels of the respiratory tract.

Magdalena Paplińska-Goryca1, Patrycja Nejman-Gryz, Ryszarda Chazan, Hanna Grubek-Jaworska.   

Abstract

Airway epithelium acts as multifunctional site of response in the respiratory tract. Epithelial activity plays an important part in the pathophysiology of obstructive lung disease. In this study, we compare normal human epithelial cells from various levels of the respiratory tract in terms of their reactivity to pro-allergic and pro-inflammatory stimulation. Normal human nasal, bronchial and small airway epithelial cells were stimulated with IL-4 and IL-13. The expressions of the eotaxins IL-6 and CXCL8 were evaluated at the mRNA and protein levels. The effects of pre-treatment with IFN-γ on the cell reactivity were measured, and the responses to TNF-α, LPS and IFN-γ were evaluated. All of the studied primary cells expressed CCL26, IL-6 and IL-8 after IL-4 or IL-13 stimulation. IFN-γ pre-treatment resulted in decreased CCL26 and increased IL-6 expression in the nasal and small airway cells, but this effect was not observed in the bronchial cells. IL-6 and CXCL8 were produced in varying degrees by all of the epithelial primary cells in cultures stimulated with TNF-α, LPS or IFN-γ. We showed that epithelial cells from the various levels of the respiratory tract act in a united way, responding in a similar manner to stimulation with IL-4 and IL-13, showing similar reactivity to TNF-α and LPS, and giving an almost unified response to IFN-γ pre-stimulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297684      PMCID: PMC6275597          DOI: 10.2478/s11658-013-0107-y

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


Supplementary material, approximately 244 KB.
  44 in total

1.  TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

Authors:  Christopher E Brightling; Fiona A Symon; Surinder S Birring; Peter Bradding; Ian D Pavord; Andrew J Wardlaw
Journal:  J Allergy Clin Immunol       Date:  2002-12       Impact factor: 10.793

Review 2.  The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis.

Authors:  Charles H Feng; Michaela D Miller; Ronald A Simon
Journal:  Am J Rhinol Allergy       Date:  2012 May-Jun       Impact factor: 2.467

3.  Effects of IL-13 on mucociliary differentiation of pediatric asthmatic bronchial epithelial cells.

Authors:  Surendran Thavagnanam; Jeremy C Parker; Michael E McBrien; Grzegorz Skibinski; Liam G Heaney; Michael D Shields
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

Review 4.  Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation.

Authors:  K B Adler; B M Fischer; D T Wright; L A Cohn; S Becker
Journal:  Ann N Y Acad Sci       Date:  1994-05-28       Impact factor: 5.691

5.  Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB.

Authors:  Ikuko Kobayashi; Shuichi Yamamoto; Natsuko Nishi; Kohsuke Tsuji; Miyoko Imayoshi; Shigeyasu Inada; Tomohiro Ichiamaru; Yuhei Hamasaki
Journal:  Ann Allergy Asthma Immunol       Date:  2004-10       Impact factor: 6.347

Review 6.  Rhinitis and asthma: evidence for respiratory system integration.

Authors:  Alkis Togias
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

7.  Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies.

Authors:  Catherine M McDougall; Morgan G Blaylock; J Graham Douglas; Richard J Brooker; Peter J Helms; Garry M Walsh
Journal:  Am J Respir Cell Mol Biol       Date:  2008-05-15       Impact factor: 6.914

8.  Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway.

Authors:  Xiao-Hong Xie; Helen K W Law; Li-Jia Wang; Xin Li; Xi-Qiang Yang; En-Mei Liu
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

9.  Maintenance of rat hepatocytes under inflammation by coculture with human orbital fat-derived stem cells.

Authors:  Xia Chen; Shichang Zhang; Tao Liu; Yong Liu; Yingjie Wang
Journal:  Cell Mol Biol Lett       Date:  2012-06       Impact factor: 5.787

10.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more
  4 in total

Review 1.  Management of chronic rhinosinusitis in asthma patients: is there still a debate?

Authors:  Eduardo Lehrer; Joaquim Mullol; Freddy Agredo; Isam Alobid
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

2.  E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke.

Authors:  Elizabeth M Martin; Phillip W Clapp; Meghan E Rebuli; Erica A Pawlak; Ellen Glista-Baker; Neal L Benowitz; Rebecca C Fry; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-10       Impact factor: 5.464

3.  Susceptibility of primary human airway epithelial cells to Bordetella pertussis adenylate cyclase toxin in two- and three-dimensional culture conditions.

Authors:  Maria Bianchi; Rinu Sivarajan; Thorsten Walles; Stephan Hackenberg; Maria Steinke
Journal:  Innate Immun       Date:  2020-12-14       Impact factor: 2.680

4.  In vitro impact preliminary assessment of airborne particulate from metalworking and woodworking industries.

Authors:  Ilona Pavlovska; Anna Ramata-Stunda; Zanna Martinsone; Martins Boroduskis; Liene Patetko; Inese Martinsone; Anita Seile; Ivars Vanadzins
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.